Mergers and Acquisitions Pandion Therapeutics from 4/1/21

News editor
press@blackterminal.com

Merck has completed its acquisition of Pandion Therapeutics for $60 per share.

Pandion Therapeutics

Review

Source:

News editor

Write your comment first

News feed

Yesterday at 20:46 AFKS

Yesterday at 20:42 RZSB

Yesterday at 17:42 MOEX

Yesterday at 16:59 MGTS

Yesterday at 14:40 ZVEZ

Yesterday at 14:37 ZVEZ

Yesterday at 14:32 VKCO

Yesterday at 14:26 SAGO

Yesterday at 14:22 SAGO

Yesterday at 12:40 SVCB